Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Local Anesthetic Systemic Toxicity – Single-center Retrospective Cross-sectional Study
ChiCTR2500101633Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in local anesthetic systemic toxicity (LAST) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Incidence of local anesthetic systemic toxicity (LAST). Planned start Apr 2025; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
local anesthetic systemic toxicity (LAST)
Beyond the preview
Go deeper on ChiCTR2500101633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101633.